Key facts
- This page summarizes Joseph Todisco's Form 4 filing for Amneal Pharmaceuticals, Inc. (AMRX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 May 2022, 18:58.
Joseph Todisco - 07 May 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- AMRX
- Reported as of
- 07 May 2022
- Net transaction value
- -$5,311
- SEC form
- 4
- Accepted by SEC
- 10 May 2022, 18:58:16 UTC
- Prior SEC filing
- 22 Mar 2022
- Next SEC filing
- 12 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Meredith Cook, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph Todisco filed Form 4 for Amneal Pharmaceuticals, Inc. (AMRX) on 10 May 2022.
Change
- Previous filing in this sequence was filed on 22 Mar 2022.
- Current net transaction value: -$5,311.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +4,442
- Change %
- +1.4%
- Price
- Shares after
- 328,756
- Date
- 07 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2
AMRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- $5,311
- Shares
- -1,562
- Change %
- -0.48%
- Price
- $3.40
- Shares after
- 327,194
- Date
- 07 May 2022
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,442
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 07 May 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 4,442
- Exercise price
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Footnote F3
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
Footnote F4
On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.